Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Contract Win

24 Feb 2014 07:00

RNS Number : 6915A
Redcentric PLC
24 February 2014
 



24 February 2014

Redcentric plc

 ("Redcentric" or "the Group")

Contract Win

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider, is pleased to announce a major contract win with an NHS partner, on a project to deliver enhanced IT infrastructure for the health and social care sector.

 

The contract was won and will be fulfilled by Intechnology Managed Services Limited, the wholly owned subsidiary acquired by Redcentric in December 2013. The NHS client awarded the contract having recognised that Redcentric is one of a handful of managed service providers to offer an accredited N3 connection service across a number of geographically dispersed state-of-the-art data centres with proven expertise in delivering Cloud services to the health sector. The contract is a multi-year agreement with annual revenues from the initial deployment expected to be a seven figure sum.

 

As a result of this partnership, the NHS client will benefit from cost savings, 24/7/365 hands and eyes support, and impressive levels of data centre and network resilience. Furthermore, the Group's accreditations ensure strict information governance, enabling it to provide the most robust environment to support such critical national programs.

 

Fraser Fisher, Chief Operating Officer of Redcentric commented: "I am encouraged to see InTechnology continuing to win large and complex contracts. This win leverages the enlarged Group's data centre and network assets and our service offering is supported by a wealth of industry accreditations and a proven capability in the healthcare sector."

Enquiries:

Redcentric plc

Tony Weaver, Chief Executive

Fraser Fisher, Chief Operating Officer

 

Tel. +44 (0)845 034 1111

N+1 Singer - Nomad & Joint Broker

Tel: +44 (0)20 7496 3000

Jonny Franklin-Adams / Ben Wright

 

finnCap - Joint Broker

Tel: +44 (0)20 7220 0500

Charlotte Stranner / Stuart Andrews

 

MXC Capital Advisory LLP - Corporate Finance Adviser

Marc Young

 

Tel. +44 (0)20 7965 8149

Newgate Threadneedle - Financial PR

Josh Royston / Hilary Millar

Tel. +44 (0)20 7653 9850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTBRGDDLDDBGSB
Date   Source Headline
31st May 202411:46 amRNSForm 8.5 (EPT/NON-RI)
31st May 20249:23 amPRNForm 8.3 - Redcentric Plc
30th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
30th May 202410:34 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:49 amPRNForm 8.3 - Redcentric Plc
29th May 20243:13 pmRNSForm 8.3 - Redcentric PLC
29th May 202411:43 amRNSForm 8.5 (EPT/NON-RI)
29th May 20249:30 amPRNForm 8.3 - Redcentric Plc
29th May 20247:00 amRNSForm 8.3 - Redcentric plc
28th May 20245:17 pmRNSForm 8.3 - Redcentric plc
28th May 20243:57 pmRNSForm 8.3 - Redcentric plc
28th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
28th May 20242:28 pmRNSSI Redstone LLP - Form 8.3 - Redcentric plc
28th May 20241:35 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
28th May 20241:16 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th May 202411:49 amRNSForm 8.3 - Redcentric plc
28th May 202411:06 amRNSForm 8.3 - Redcentric PLC
28th May 202410:24 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:56 amPRNCorrection: Statement regarding Redcentric plc ("Redcentric")
28th May 20249:13 amPRNStatement regarding Redcentric plc ("Redcentric")
24th May 20244:19 pmRNSResponse to press speculation
16th May 20247:00 amRNSTrading Update
14th May 20241:00 pmRNSExercise of Options
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.